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Mitochondrial quality control has an impact on many diseases, 
but intense research has focused on the 
action of 2 genes linked to heritable 
forms of Parkinson disease (PD), PINK1 
and PARK2/parkin, which act in a com-
mon pathway to promote mitophagy. 
However, criticism has been raised that 
little evidence links this mechanism to 
sporadic PD. To gain a greater insight 
into the mechanisms of PINK1-PARK2 
mediated mitophagy, we undertook a 
genome-wide RNAi screen in Drosophila 
and human cell models. Strikingly, we 
discovered several components of the 
lipogenesis pathway, including SREBF1, 
playing a conserved role in mitophagy. 
Our results suggest that lipids influence 
the stabilization of PINK1 during the 
initiation of mitophagy. Importantly, 
SREBF1 has previously been identi-
fied as a risk locus for sporadic PD, and 
thus implicates aberrant mitophagy as 
contributing to sporadic PD. Our find-
ings suggest a role for lipid synthesis in 
PINK1-PARK2 mediated mitophagy, 
and propose a mechanistic link between 
familial and sporadic PD, supporting a 
common etiology.
Parkinson disease is a neurodegen-
erative movement disorder in which 
abnormal mitochondrial homeostasis 
is a common and consistent pathologi-
cal feature. Over the past 20 y, genetic 
analyses of patients with PD have identi-
fied several genes whose mutation leads to 
the development of familial parkinson-
ism. A number of these genes play a role 
in maintaining a healthy mitochondrial 
network, underscoring the importance of 
mitochondrial homeostasis in PD. While 
these discoveries have greatly strength-
ened our understanding of the causes of 
familial PD, there has been much debate 
in the field over its relevance to the more 
common sporadic forms of PD.
Compelling insights have come from 
studying 2 PD-causing genes with an 
undisputed role in mitochondrial homeo-
stasis, PINK1 and PARK2, which encode a 
mitochondrially-targeted serine-threonine 
kinase and a cytoplasmic E3-ubiquitin 
ligase, respectively. These genes act in 
a common pathway, coordinating the 
removal of failing mitochondria via 
mitophagy. Substantial evidence sup-
ports the idea that following mitochon-
drial injury PINK1 is stabilized on the 
outer mitochondrial membrane (OMM) 
and signals the recruitment of PARK2, 
whereupon it promiscuously ubiquitinates 
many mitochondrial proteins, labeling the 
organelle for destruction. Since its incep-
tion this mechanism has proven to be a 
polarizing idea in the field. Proponents 
find it an attractive mechanism that can 
explain several features of the disease, 
such as accumulation of oxidative dam-
age, elevated mitochondrial DNA muta-
tions, and cell-type selectivity in neurons 
with extreme demands on energy and 
calcium regulation. However, critics often 
retort that there is currently little direct 
evidence for this mechanism in vivo, and 
even less linking it to sporadic PD, hold-
ing this absence of evidence to be suffi-
cient evidence of absence.
To gain a greater understanding of the 
mechanism of mitophagy, we performed 
a genome-wide RNAi screen for modu-
lators of toxin-induced mitochondrial 
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the SREBF1 locus alters the expression of 
SREBF1, thereby promoting pathogenesis. 
We hypothesize that this is due to reduced 
SREBF1 expression inhibiting mitophagy. 
While our findings are in no way defini-
tive, they provide further circumstantial 
evidence that defective mitophagy may 
play a role in the pathology of sporadic 
PD. Such findings also form a mechanis-
tic bridge between the etiology of familial 
and sporadic PD, suggesting a common 
cause.
Disclosure of Potential Conflicts of Interest
No potential conflicts of interest were 
disclosed.
Acknowledgments
The original work was funded by a 
Wellcome/MRC Parkinson’s Disease 
Consortium grant to UCL/IoN, the 
University of Sheffield, and the MRC 
Protein Phosphorylation Unit at the 
University of Dundee (WT089698), the 
MEFOPA project funded through the 
European Union FP7 research program, 
and an ERC Starting Grant (no. 309742).
translocation of PARK2. The initial 
screen was performed in Drosophila S2R+ 
cells to take advantage of reduced genetic 
redundancy in this model system and to 
define conserved mediators of mitophagy. 
A primary hit group of Drosophila genes 
were identified that prevent park translo-
cation and other aspects of Pink1-related 
mitochondrial homeostasis, including 
alterations in mitochondrial morphology 
and perinuclear aggregation of mitochon-
dria. To define functionally conserved fac-
tors, the homologous human genes were 
tested for their affects on PARK2 translo-
cation and mitophagy in HeLa cells. This 
approach produced a hit group of 20 con-
served genes that promote mitophagy. Of 
these, 4 genes are known to form part of 
the major sterol regulatory element bind-
ing protein (SREBP) lipogenesis pathway; 
SREBF1 and SREBF2, master transcrip-
tion factors, and FBXW7 and GSK3A, 
pathway regulators. This strongly sug-
gested a mechanistic link between the 
synthesis of lipids and mitophagy.
We next performed a series of tests 
to verify that the observed effects were 
due to the interference of the lipogenesis 
pathway. First, we found that a chemical 
inhibitor of SREBP activation, genistein, 
reproduces the block in PARK2 trans-
location seen with SREBF1 siRNA. We 
also showed that the SREBF1-dependent 
block in PARK2 translocation can be 
partially rescued by the addition of exog-
enous lipids, both fatty acids and choles-
terol. These results support a role for the 
canonical SREBP pathway in PARK2 
translocation and suggest that the syn-
thesis of lipids by SREBP target genes is 
necessary for effective PINK1-PARK2 
mediated mitophagy.
To gain insight into potential mecha-
nisms by which lipids could be affecting 
mitophagy, we next looked upstream of 
PARK2 translocation. Following mito-
chondrial injury full-length PINK1 
becomes stabilized on the OMM. Both 
SREBF1 silencing and genistein treat-
ment lead to a decrease in the stabiliza-
tion of PINK1. These results suggest that 
SREBF1 loss may block mitophagy by 
reducing the degree to which full-length 
PINK1 is stabilized on the OMM of 
injured mitochondria. Intriguingly, the 
exogenous addition of lipids produces a 
clear trend toward rescued PINK1 sta-
bilization, though none of the condi-
tions reached significance in this assay. 
Nevertheless, overall our findings suggest 
that SREBF1-dependent lipid synthesis 
may be a key factor in PINK1 OMM 
stabilization (Fig. 1). How alterations in 
the lipidome cause a change in PINK1 
dynamics is not yet understood. It could 
be that alterations in the mitochondrial 
membrane lipid composition lead to a 
weakened association of PINK1 with 
the OMM. Alternatively, reduced lipid 
synthesis could deprive mitochondria of 
signaling events upstream or independent 
of PINK1 stabilization, such as the exter-
nalization of cardiolipin. Clearly, further 
work is needed clarify these mechanisms.
While this study provides novel insight 
into how the PINK1-PARK2 pathway 
coordinates the elimination of dysfunc-
tional mitochondria, the broader signifi-
cance of this work comes from the finding 
that SREBF1 has been identified as a risk 
locus for idiopathic PD in genome-wide 
association studies. A parsimonious impli-
cation of this is that genetic variation at 
Figure 1. proposed model for lipid influence on pinK1 stabilization on dysfunctional mitochon-
dria. under normal conditions, pinK1 is targeted to the mitochondrion via its mitochondrial target-
ing sequence (mtS) where it is imported by the translocase of outer membrane (tomm) complex. 
upon reduction in mitochondrial membrane potential (ΔΨm) full-length pinK1’s import is abol-
ished and it becomes stabilized on the outer membrane, whereupon it stimulates mitophagy via 
the recruitment of pARK2 (not shown). our data show that loss of the SREBF1 pathway and deficient 
lipogenesis significantly reduces full-length pinK1 stabilization, inhibiting mitophagy. We hypoth-
esize that the dysregulation of certain lipids or membrane-lipid composition leads to reduced 
pinK1 stabilization by reducing recruitment or import, or interfering with membrane tethering. 
other engulfment signals such as cardiolipin externalization may also be affected.
